Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.524 USD | +312.60% |
|
+312.60% | +2.75% |
04-02 | CYduct Diagnostics, Inc. Announces Positive Study Results for Biomarker Combinations in the Assessment of Breast Cancer | CI |
2021 | CYduct Diagnostics, Inc. announced a financing transaction | CI |
Sales 2010 | 429K 33.96M | Sales 2011 | 329K 25.99M | Capitalization | 396K 31.34M |
---|---|---|---|---|---|
Net income 2010 | -1M -79.08M | Net income 2011 | - 0 | EV / Sales 2010 | 0.87 x |
Net Debt 2010 | 265K 20.98M | Net Debt 2011 | 167K 13.21M | EV / Sales 2011 | 1.71 x |
P/E ratio 2010 * |
-
| P/E ratio 2011 |
-
| Employees | 4 |
Yield 2010 * |
-
| Yield 2011 |
-
| Free-Float | 0% |
1 day | +312.60% | ||
1 week | +312.60% | ||
Current month | +71.80% | ||
1 month | +312.60% | ||
3 months | +74.67% | ||
6 months | +16.44% | ||
Current year | +2.75% |
![Extreme 0.127](/images/extremecours_fleche.png)
![Extreme 0.127](/images/extremecours_fleche.png)
![Extreme 0.127](/images/extremecours_fleche.png)
![Extreme 0.127](/images/extremecours_fleche.png)
![Extreme 0.0719](/images/extremecours_fleche.png)
![Extreme 0.06](/images/extremecours_fleche.png)
![Extreme 0.06](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Dominick Gatto
CEO | Chief Executive Officer | 63 | 14/06/17 |
Claus Madsen
DFI | Director of Finance/CFO | - | - |
Michael Stewart
COO | Chief Operating Officer | 66 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Stewart
COO | Chief Operating Officer | 66 | - |
Dominick Gatto
CEO | Chief Executive Officer | 63 | 14/06/17 |
Date | Price | Change | Volume |
---|---|---|---|
21/06/24 | 0.524 | +312.60% | 983 |
Delayed Quote OTC Markets, June 21, 2024 at 02:49 pm
More quotes- Stock Market
- Equities
- CYDX Stock